Results 121 to 130 of about 186,128 (186)

A multicenter, single-arm study using a modified faricimab treat-and-extend regimen in patients with macular edema due to central retinal vein occlusion: RVOSTAR study design protocol. [PDF]

PLoS One
Kondo M, Shimura M, Tsujikawa A, Muraoka Y, Kogo T, Akiyama Y, Hama Y, Tsujimura J, Iwasaki K, Kamei M.   +9 more
europepmc   +1 more source

Novel metrics for evaluating decision making in a 'Treat and Extend' regimen for neovascular age related macular degeneration. [PDF]

Eye (Lond), 2022
McLeish B, Morris A, Karpoor M, Babar T, Narendran N, Yang Y.   +5 more
europepmc   +1 more source

Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials. [PDF]

Ophthalmol Ther
Friedman SM, Xu Y, Sherman S, Kuznik A, Mojebi A, Keeping S, Chan K, Leng T, Patel N.   +8 more
europepmc   +1 more source

Infographic: Efficacy and safety of intravitreal aflibercept treat-and-extend regimens in exudative age-related macular degeneration: ALTAIR study. [PDF]

Eye (Lond)
Barai I, Mathew RG, Sivaprasad S, Henein C.   +3 more
europepmc   +1 more source

Treat-and-Extend vs. Pro Re Nata Regimen of Ranibizumab for Diabetic Macular Edema-A Two-Year Matched Comparative Study. [PDF]

Front Med (Lausanne), 2021
Lai TT, Chen TC, Yang CH, Yang CM, Ho TC, Hsieh YT.   +5 more
europepmc   +1 more source

Two-year Outcomes of Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration with "Observe before Treat-and-Extend" Method. [PDF]

Korean J Ophthalmol
Moon JY, Kim HJ, Cho SC.
europepmc   +1 more source

A post-hoc analysis of intravitreal aflibercept-treated nAMD patients from ARIES & ALTAIR: predicting treatment intervals and frequency for aflibercept treat-and-extend therapy regimen using machine learning. [PDF]

Graefes Arch Clin Exp Ophthalmol
Gutfleisch M, Heimes-Bussmann B, Aydin S, Petrovic R, Loktyushin A, Ohji M, Takahashi K, Okada AA, Scholz P, Youssef H, Bauer-Steinhusen U, Machewitz T, Rothaus K, Lommatzsch A.   +13 more
europepmc   +1 more source

Das modifizierte Treat-and-Extend-Schema mit Injektionsblöcken in der IVOM-Therapie

, 2021
Take, Patricia, Dittmann, Carolin Alisa, Mackerodt, Laura, Callizo, Josep, Striebe, Nina-Antonia, Hoerauf, Hans, Feltgen, Nicolas, Bemme, Sebastian   +7 more
openaire   +1 more source

One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study. [PDF]

Ophthalmol Ther
Yozgat Z, Isik MU, Sabaner MC.
europepmc   +1 more source

The Reinforced Treat-and-Extend Protocol for Exudative Age-Related Macular Degeneration: Retrospective Assessment of 24-Month Real-World Outcomes in France. [PDF]

Ophthalmol Ther
Roubelat FP, Barioulet L, Varenne F, Escudier C, Meyer P, Gomane C, Butterworth J, Pagot-Mathis V, Fournié P, Gualino V, Soler V.   +10 more
europepmc   +1 more source